Exicure Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$2.08

-0.12 (-5.45%)

As of Jun 30, 10:43 PM ET ·

Analyst Consensus

Strong Sell

Analysts

Moderate

Coverage

Buy 0 0%

Hold 3 50%

Sell 3 50%

Price Target

Analyst Price Target +1,381.7% upside

Low Target $21.30

Average Target $30.82

High Target $34.43

Current Price $2.08

Current
$2.08

Target
$30.82

$21.30 $30.82 avg $34.43

Scenario Analysis

Bear Case

$21.30

924.0%

Low target

Base Case

$30.82

+1,381.7%

Avg target

Bull Case

$34.43

+1,555.3%

High target

Risk/Reward

1.7x

Balanced

Price in Context

52-Week High

$9.50

-78.1% from high

52-Week Low

$1.71

+21.6% from low

Target vs 52W High

$30.82

+224.4% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+2.4%
AMGN Amgen Inc	Hold	44	50%	$190.87	-47.3%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+187.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.8%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.7%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-66.0%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-39.1%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-47.4%